NCT00622362View on ClinicalTrials.gov

Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract

PHASE2TerminatedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

February 28, 2009

Study Completion Date

February 28, 2009

Conditions
Allergic Asthma
Interventions
BIOLOGICAL

DEPIGOID Dermatophagoides pteronyssinus

Subcutaneous administration:0.5 ml/month during 1 year

BIOLOGICAL

Polymerized TOL of Dermatophagoides pteronyssinus

Sublingual immunotherapy. Two drops daily during 1 year

BIOLOGICAL

Placebo Comparator

Sublingual immunotherapy. Two drops daily during 1 year

Trial Locations (1)

46009

Hospital Universitario La Fé, Valencia

Sponsors
All Listed Sponsors
lead

Laboratorios Leti, S.L.

INDUSTRY

NCT00622362 - Subcutaneous-Sublingual Immunotherapy With Depigmented and Polymerized Dermatophagoides Pteronyssinus Allergen Extract | Biotech Hunter | Biotech Hunter